Evorel

In the US, Evorel is a member of the drug class estrogens and is used to treat Atrophic Urethritis, Atrophic Vaginitis, Breast Cancer - Palliative, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms, Primary Ovarian Failure and Prostate Cancer.

UK matches:

• Evorel 25, 50, 75 & 100 patches (SPC)
• Evorel Conti (SPC)
• Evorel Conti & Sequi (Janssen-Cilag Ltd) (SPC)
• Evorel Sequi (SPC)

Ingredient matches for Evorel

Estradiol

Estradiol is reported as an ingredient of Evorel in the following countries:

• Argentina


• Bangladesh


• Denmark


• Iceland


• Ireland


• Israel


• Norway


• United Kingdom

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Evorel in the following countries:

• Antigua & Barbuda


• Aruba


• Bahamas


• Barbados


• Bermuda


• Cayman Islands


• Costa Rica


• Dominican Republic


• El Salvador


• Finland


• Grenada


• Guatemala


• Guyana


• Honduras


• Jamaica


• Malta


• Mexico


• Netherlands Antilles


• Nicaragua


• Panama


• Saint Lucia


• Saint Vincent & The Grenadines


• South Africa


• Suriname


• Sweden


• Trinidad & Tobago


• United Kingdom

Norethisterone

Norethisterone 17ß-acetate (a derivative of Norethisterone) is reported as an ingredient of Evorel in the following countries:

• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.